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Type IV collagenases have been shown to play an important 
role in tumor metastasis and wound healing. In the present 
study, we have demonstrated the presence of 72-kDa and 
92-kDa forms of type IV collagenase in human skin by bio-
chemical and ill situ hybridization techniques .II1 situ hybrid-
ization allowed us to localize the 72-kDa form mostly to 
fibroblasts and the 92-kDa form to the epidermis and endo-
the lial cells. The presence of type IV coll agenase was con-
firmed by Western blotting. Enzyme activity was assayed in 
spontaneous blisters (18 subjects) and suction-induced blis-
ters (29 subjects) by the zymography method, and by using 
type IV collagen as the substrate. Thus, it was possible to 
detect both the 92-kDa and 72-kDa forms in spontaneous 
and induced blisters. An especially high level of the 92-kDa 
T ype IV collagenases, which belong to the matrix me-talloproteinases family [1 J, form a group of enzymes that have th e abi lity to degrade basement membrane collagen [2J and some other components such as elas-tin [3J and other collagen types V, VII, and X [4 - 7J . 
At least two distinct forms of type IV collagenase of7 2-kDa (MMP-
2) and 92-kDa (MMP-9) have been found [1 J. These enzymes are 
synthesized by various cel ls such as fibroblasts, keratinocytes, and 
inflammatory cell s [2J . Especially 72-kDa collagenase is produced 
by fibrobl astic cells, and 92-kDa form mainly by inflammatory cells 
and keratinocytes [2,8J . Type IV collagenases have been suggested 
to have an important role in many biologic and pathologic proc-
esses, such as wound healing, angiogenesis, embryonic develop-
me nt, inflammation, and tumor metas tasis [2,8 -11 J. 
The role and localization of type IV collagenase in human skin 
has not been thorou ghl y studied. In this paper, we have studied type 
IV coll age nases in various blistering diseases and in healthy skin, 
and their regulation by topical glucocorticoids. The resu lts demon-
strate that both 72-kDa and 92-kDa forms of type IV collagenase are 
expressed in human skin and are induced during re-epithelialization 
and decreased by topica l glucocorticoids. By ill situ hybridization 
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enzyme was found in a bullous pemphigoid patient. 
T ype IV collagenases were studied during re-epithelializa-
tion of the blister, using the suction-blister model. There was 
a marked induction of the 92-kDa type that was confirmed to 
be in the regenerating, migratory, epithelium by in situ hy-
bridization studies. These results indicate that 92-kDa type 
IV collagenase may play an essential role in the normal phys-
iology and integrity of the skin and may be an important 
regulator of re-epithelializa tion. It was also shown that po-
tent topical glucocorticoid down-regulated the 92-kDa type 
collagenase, suggesting that glucocorticoids may have a ben-
eficial role in some skin diseases by decreasing type IV colla-
genase activity and, thus, reducing tissue destruction.] IrlJlest 
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studies it was possible to localize these coll agenase types to distinct 
compartments of the skin. 
PATIENTS AND METHODS 
In the fi rst part of the study, blister-fluid samples were col lected from spon-
taneous blisters of 18 patients. The clinical data from these patients is 
presented in Table I. The samplcs were taken before any specific treatment. 
In onc patient (number 7), blister-fluid samples were also taken aftcr 5 d 
treatment w ith dapsone. From some patients biopsics were obtained for 
routine histologic and immunohis tochemical analyses. 
In the second part of the study, suction blisters were induced on the 
abdominal skin of 29 voluntary male subjects (ages 19 -22) as described 
previously [1 2]. The diagnoses included atopic eczema (n = 20), psoriasis 
vulgaris (n = 2), condyloma accuminata (n = 2) , erysipelas cruris (n = 1), 
herpes simplex (n = I) , atheromata scrotalis (n = 1), eczema nummulare 
(n = I), and hyperhidrosis palmoplantaris (n = 1). The blisters were in-
duced on the clinica lly healthy skin. To study the effect of re-epithelializa-
tion on type IV collagenase, blister-fluid samples were taken by a Mantoux 
syringe immediately after bliste r forma tion and at 24 or 72 h post-blistering. 
For each sample, 2 - 3 intact blisters wcrc emptied and pooled and thc re-
maining blisters wcre protected by a cap until used. Pooled samples werc 
kept frozen at - 20 · C until assayed. 
To study the effect of topical glucocorticoid, or al l-trans rctinoic acid , on 
rype IV co llagenase, glucocorticoid creams (hydrocortisone (Uniderm) , hy-
drocortisone-17-butyrate (Locoid) , clobetasol-17-propionate (Dermovate) 
all-trailS retinoic acid (Avitcid 0.1 %), or vehicle were app lied three times a 
day on the abdominal ski n fo r 1 to 4 d, until blisters were induced, as 
indicated in Results and ill the fi gure legends. 
For ill situ hybridiza tion studies, whole suction blisters were removed 
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Table I. Clinical Data of Patients with Bullo us Diseases and Type IV Coll agen ase Activity in Blister Fluids 
Type IV Collagenase Activ ity 
Densitometric Units' 
Localization Patient Age Ratio 
Number Diagnosis' (years)/sex of blister Dpmb 72 kDa 92 kDa 92 kOaj72 kDa 
1 Ery 73/M 1270 97.4 272.0 2.78 
2 Ery 58/F Lower leg 572 217.3 264.2 1.22 
3 Ery 73/P Arm 711 186.3 150.4 0.8 1 
4 Ery 22/M 1406 ND' ND ND 
5 BP 69/M NO 153.9 555.1 3.57 
6 BP 73/F ND 20 1.4 423.0 2.08 
7 BP 74/M Lower leg ND 113.5 (46.4)' 2215.0 (41 2.6)' 20.0 
8 BP 70/F Lower leg 260 99.9 224.0 2.22 
9 BP 64/F 771 ND ND ND 
10 Pompholyx 32/M Arm 2002 36.2 158.9 4.35 
11 Pompholyx 46/M Arm ND 11 9.6 519.6 4.35 
12 EM 26/M Arm ND 62.6 363.4 5.88 
13 EM 38/M Arm 1060 ND ND ND 
14 RA 52/F Lower leg ND 237 .5 590.3 2.50 
15 RA 63/F NO 340.2 667.2 1.96 
16 RA 75/F Lower leg NO 94. 1 174.7 1.85 
17 cn 26/M ND 117.6 415.2 3.57 
18 CB 25/M Genital ND 67.4 331.7 5.00 
• Ery, erysipelas; BP, bullous pemphigoid;EM,. eryth~ma multiforme; RA, rheumato.ides arthritis (friction bulla); CB, "ryo blisters induced by liquid nitrogen. 
• Type IV co llagenase was assayed as descnbed 111 Patrellts "lid Met/lods, uSll1g ('H)prolzne-I.beled rype IV co llagen as substtate. The activiry is expressed as dpm per 50 "I blister 
sample. 
, 72-kDa and 92-kDa rype IV co llagenases were assayed by zymography. The activ ities arc expressed as densitometric uni ts (5 "I . Iiquots were used for assay). 
J In patient 7, blister Auids were also collected after treatment with dapsone for 5 d. 
'NO, not determined. 
under local anesthesia immediately after blister formation and 24, 48, and 
72 h later. The samples were then processed as described below. All the 
samples were taken according to the rules of the Helsinki declaration. 
Assay of Type IV Collagenase Activity The reaction was carried out as 
previously described [1 3]. BrieRy, the enzyme was acti vated by treatment 
with trypsin (10 J.lg/ml) for 10 min at 35 °C, fo llowed by the addition of 
soybean trypsin inhibitor (40 J.lg/ml) and N-ethylmaleimide (4 mM). 
eH}proline-labeled type IV collagen (4000 cpm/reaction) was added as 
substrate and 'the reaction was allowed to proceed for 18 h at 35 °C , in a fin al 
volume of 650 ILl. The reaction was terminated by the addition of 20 J.ll of 1 
mg/ml bovi ne serum albumin and 100 J.l l of a solution containing 10% 
trich loroacetic acid and 5% tannic acid . After a 30-min incubation on ice, the 
mixture was centrifuged at 10,000 X g for 15 min and the radioactivity of 
the supernatant was measured in a sc intillation counter. 
Zylllogrtlplly: For zymography, the method of Heussen and Dowdle [14] 
was used, except that the substrate was gelatin labeled with 2-methoxy-2,4-
diphenyl-3(2H)-furanone (Fluka, Ronkonkoma, NY), according to the 
merhod of O'Grady et al [1 5]. The advantage of this method is thar the lysis 
can be monitored visua lly, or by photograph ic inspection under long-wave 
ultraviolet light, and the capacity of proteins in the samples to bind Coomas-
sie brilliant blue does not affect the pattern of lysis. Prior to electrophores is, 
samples for zymography were pre-incubated at 22 °C fo r 1 h with 1 % so-
dium dodecylsul fate (SDS) and electrophoretic sample buffer, and pre-
stained molecular weight standard proteins were reduced with 5% 2-mer-
captoethanol. Zymography was performed in 1.5 mm 10% polyacrylamide 
slab gels containing 2 mg/ml gelatin. After electrophoresis, type IV colla-
genase was activated by incubating at 37"C. In each experiment the cleavage 
rates were monitored under long-wave ultrav iolet illumination, and activa-
tion was continued until visually clear bands could be observed. In these 
experiments ac tivation time was usually overnight. After the activation was 
finished the gels were photographed under long-wave ultraviolet illumina-
tion. C leavage rate estimates were made by determining the rates of disap-
pearance of the gelatin by densitometric scanning at the negatives of the 
photographed gels using a Computing Densitometer model 300A (Molecu-
lar Dynamics). To establish the conditions for assay of type IV collagenase, a 
standard curve was performed by using various amounts of blister fluid. The 
cleavage rate was linear at least between 1 to 10 J.l1 of blister Ruid (not 
shown). In some patients blisters were induced repeatedly and zymograms 
were compared from these. The variability in enzyme activity between 
different blisters induced on the same subjects was relative ly small, usually 
less than ten percent. In one series of experiments, zymograms were incu-
bated for 4 h at 37 °C with control buffer, 25 mM ethylenediaminetetraace-
tic acid, 1 mM 1,10 phenan throline, or 2 Ilg/ml of recombinant human 
inhibitor of metalloproteinase, a gift from Dr. David Carmichael (Synergen, 
Boulder, Co.). In some experiments blister roofs (blister roofs of six blisters 
were pooled) were immediately froze n after blister induction and kept at 
-70· C. Samples were then homogenized in 50 J.ll of sample buffer and 
25111 was used for zymography assay. 
Western Immunoblotting Aliguots of th e blister Ruids were electro-
phoresed in a 10% SOS-polyactylamide gel and blotted onto nitrocellulose. 
The nitrocellulose membrane was blocked with 5% nonfat milk/ phos-
phate-buffered saline [or 45 min, and incubated overni ght, at room tempera-
ture, with rabbit anti - 72-kDa type IV collagenase IgG, diluted 1 : 500 
(kindly prov ided by Dr. Birkedal-Hansen) and goat anti -92-kDa type IV 
collagenase (kindly provided by Dr. Murphy). Biotinylated anti-rabbit and 
anti-goat immunoglobulins (1 : 500 aad 1 : 100, and avidin-biotia complex, 
horserad ish peroxidase (ABC/HPP, Dako)/ 3,3-diaminobenzidine tetrahy-
drochloride were used to develop th e blots. 
RNA Probes and In Situ Hybridization Skin biopsies from eight cases 
of suction blisters were routinely fi xed in 10% formalin and embedded ill 
paraffin. Four-micrometer sections were used for ill situ hybridization. A 
detai led description of the preparation of paraffin sections for ill s itu hybrid-
ization has been described previously [1 6]. A 635- base pair (bp) Sca I Sac I 
fragment of the K-191 human 70-kDa type IV collagenase cDNA clone [17J 
was cloned into the M13 polylinker si te of pSP64 and pSP65 vectors (Pro-
mega). A 634-bp Xba I-Hind 1II fragment of the K-174.1 human 92-kDa 
type IV collagenase cDNA clone [1 8] was cloned into the pGEM 4Z vector 
(Promega, Wisconsin). For transcription, a riboprobe transcription kit (Pro-
mega) was used and the transcripts were labeled with either 35S-rCTP or 
35S-rUTP to specific activities of3 X 106 cpm/40 ILl. All the solutions used 
with the RNA probes were treated with 0.1 % diethylpyrocarbonate (DEPC, 
Fluka). 
III sitll hybridization with anti-sense and sense RNA probes has been 
described previously [16]. The hybridizations were performed at 50· C, 
followed by washing, autoradiography for 7 - 15 d, and staining of the sec-
tions with hemotoxylin and eosin. 
In the analysis the hybridization signa l was regarded as positive only when 
there were 10 or more grains clearly concentrating within the cytoplasm of a 
cel l. Olffusely distributed grams over th e section were regarded as unspecific 
background labelin g. 
Other Assays For statistical analyses, Wilcoxon signed rank test and lin-
ear regression were used. 
RESULTS 
Demonstration of72-kDa and 92-kDa Type IV Collagenases 
in Blistering Diseases and Suction Blisters In the first set of 
experiments, type IV collagenase was assayed using 3H-labeled type 
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Figure 1. Demonstration of type IV collagenase in various blistering dis-
eases. Blister-fluid samples were collected from spontaneous blisters of 
various blistering diseases and aliquots were analyzed by zymography. The 
zymography gel is shown and the positions of the 92-kDa and 72-kDa 
enzymes arc indicated. The relativc enzyme activities are expressed as densi-
tometric units (X 10- 2). The 92-kDa enzyme is represented by the black 
coltlmlls and the 72-kDa enzyme by lilled CO II/IIlIIS. Samples in A and B were 
&om etysipelas patients (patients 2 and 3 in Table I) ; C, F, and G were from 
bullous pemphigoid patients (patients 7, 6, and 8 in Table I); D was from a 
pompholyx patient (patient 10 in Table I); and E was from a etythema 
multiforme patient (patient 12 in Table I) . 
IV collagen as the substrate. Type IV collagenase-like activity could 
be detected in all blister samples studied (see T able I). Because this 
method is relatively non-specific (other proteases such as stromely-
sin are also able to degrade type IV collagen) [7], a zymography 
method was uti lized in furth er experiments. As shown in Fig 1, 
clearly detectable type IV collagenase activity could be found in 
blis ter fluids coll ected from patients with various blistering diseases. 
Especially high activity (demonstrated several times) was observed 
in one patient with bullous pemphigoid. Type IV collagenase was 
detected as two forms of92-kDa and 72-kDa. The ratio between the 
92-kDa and 72-kDa collagenases varied in different blistering dis-
eases (Fig 1, Table I) . The ratio was higher in blister fluids obtained 
from bullous pemphigoid and pompholyx patients, and was lowest 
in blister fluid s obtained from erysipelas patients (Fig 1 and Table I). 
Type IV collagenase was detected by zymography in all th e blister 
fluids analyzed (Table I). In one patient, blister fluids were also 
collected after treatment with dapsone for 5 d (patient 7), and the 
level of type IV coll agenase was found to be decreased when com-
pared to pre-treatment levels . The 92-kDa activity was 413 densito-
metric units after the 5 d treatment with dapsone, compared to the 
pre-treatment value of 2215. 
To correlate enzyme activity and histologic findin gs, biopsy sam-
ples were obtained from some patients for routine histolo gic analy-
sis. These samples were obtained from three bullous pemphigoid 
patients (numbers 5, 7, and 8) and from one erythema multiforme 
patient (number 13). In all these samples eosinophilic granulocytes 
could be observed and in some samples also some mononuclear 
lymphocytes. However, due to the small number of samples ana-
lyzed by histology, no definite correlation between inflammation 
and type IV collagenase could be observed. 
Because type IV collagenase could be detected in blister fluids 
collected from patients with blistering diseases of different patho-
genesis, the question was raised as to whether type IV collagenase 
would also be present in suction blisters induced on the healthy skin 
of volunteers. The suction blisters were induced on the health y 
looking abdominal skin of volunteers. A total of29 volunteers were 
studied and type IV collagenase (both 92-kDa and 72-kDa forms) 
could be demonstrated in suction-blister fluids in all of them. There 
was a positive correlation between the expression of 92-kDa and 
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Figure 2. Effect of re-epithelialization and topical glucocorticoid on type 
IV collagenase in blister fluids. The abdominal skin of two patients was 
trea ted with either vehicle, or Dermovate, three times a day for 4 d until 
blisters were induced. Samples were collected 0, 24, and 72 h post-blistering 
and analyzed by zymography. The positions of the 92-kDa and 72-kDa 
enzymes are shown. 
In some experiments blister roofs after blister induction were 
homogenized and used for zymography. Both 92-kDa and 72-kDa 
enzymes could be detected in th ese samples (not shown). 
Effect of Re-Epithelialization on 72-kDa and 92-kDa Type 
IV Collagenases The suction-blister model can be used to study 
the effect of re-epithelialization of the blister base on type IV colla-
genase activity. As shown in Figs 2 and 3 by zy mography, there was 
a more than twofold induction of the 92-kDa type IV collagenase 
during re-epithelialization (p = 0.03). The changes in the 72-kDa 
form were not as marked and, in fact, the 92-kDa/72-kDa ratio 
increased significantly during re-epithelialization (p = 0.045) 
(Fig 3). 
Effect of Topical Glucocorticoid and All-Trans Retinoic 
Acid on 72-kDa and 92-kDa Type IV Collagenases In some 
patients, the effects of topical c1obetasol-17 -propionate and all-trans 
retinoic acid were studied. Topically applied c1obetasol-17 -pro-
pionate decreased the 92-kDa type IV collagenase and, interest-
ingly, the enzyme activity remained lower during re-epithelializa-
tion when compared to nOll-treated skin (Figs 2 and 3). The other 
steroids tested did not inhibit the 92-kDa enzyme as markedly as 
c1obetasol-17 -propionate (not shown). 
All-trans retinoic acid, which is extensively used for treatment of 
acne and photo-agi ng, had essentiall y no effect on the 92-kDa and 
72-kDa act ivities of type IV co llagenase w hen applied for 4 d before 
blister induction (not shown) . 
Demonstration of Type IV Collagenases in Blister Fluid and 
Keratinocytes by Western Blotting T ype IV collagenase was 
studied in blister fluid s by Western blotting. By employing anti-
bodies against the 72-kDa and 92-kDa forms, it was possible to 
confirm the presence of type IV collagenases in blister fluid (Fig 4). 
Detection of72-kDa and 92-kDa Type IV Collagenases by in 
situ Hybridization The 92-kDa type IV collagenase mRNA was 
strongly expressed in the epidermis, the signal being concentrated 
mainly in the basal and middle layers of the stratified epithelium 
(Fig 5) . The signal was especially strong in the regenerating epithe-
liUln. Although strong, the signa l seemed to be somewhat lower in 
the normal epidermis. The endothelial cells in the proliferated cap-
illaries beneath the blister area contained a clear signal for the pres-
ence of the 92-kDa type IV collagenase mRNA (Fig 5). 
The 72-kDa type IV collagenase mRNA was mainly, and 
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Figure 3. Effect of re-epithelialization and topical glucocorticoid on the 
92-kDa and 72-kDa enzymes and on the 92-kDa/72-kDa ratio in blister 
fluids. A total of four patients were treated with vehicle, or Dermovate, three 
times a day for 4 d (the zymography of two of these patients is shown in Fig 
2) . Samples were collected at 0, 24, and 72 h post-blistering and analyzed by 
zymography. The values are the mean ± SD. Statistical significances: 
changes in the 92-kDa and 72-kDa enzyme levels and in the 92-kDa/72-
kDa ratios of controls were statistically significant from 0 to 24 h (p = 0.03, 
0.045, and 0.045 respectively). In Dermovate-treated samples, 92-kDa ac-
tivity was significantly lower at all time points (p = 0.045, 0.05, and 0.061). 
The 92-kDa/72-kDa ratio was significantly lower in Dermovate-treated 
samples at 0 (p = 0.045) and 24 (p = 0.061) h. 
strongly, expressed in the fibroblastic dermal cells beneath the blis-
ters (Fig 6). A low signal was also seen in the endothelial cells, but its 
level was much lower than that observed for the 92-kDa type IV 
collagenase mRNA. Expression of the 72-kDa mRNA could also be 
detected in the normal dermal fibroblasts . Only occasional cells in 
the basal epidermis expressed mRNA for the 72-kDa type IV colla-
genase (Fig 7). This expression was detected more clearly in the 
normal epidermis than in the epithelium of the blister area. 
DISCUSSION 
In the present study we have demonstrated the presence of type IV 
collagenase in human skin by assaying its activity, by Western blot-
ting, and by in sill! hybridization. We have shown that two forms of 
type IV collagenase, of72-kDa and 92-kDa, are expressed in diff~r­
ent cells. The 92-kDa form was mainly found in epidermis and 
endothelial cells, whereas the 72-kDa enzyme was mostly expressed 
in fibroblasts. This indicates that these enzymes may have different 
roles in skin physiology and in pathologic conditions. The results 










Figure 4. Western blot analysis of blister fluid using polyclonal 72-kDa 
type IV collagenase (a) and monoclonal 92-kDa type IV collagenase anti-
bodies (b) . For Western analysis 5 /-11 aliquots of blister fluid (collected from 
patient number 7) were run, non-reduced, on a 10% SDS - polyacrylamide 
gel electrophoretogram, blotted onto nitrocellulose, reacted with anti- 72-
kDa type IV collagenase and anti - 92-kDa type IV collagenase antibodies 
and visualized with a second antibody conjugated to biotin-avidin complex 
horseradish peroxidase. The position of the pre-stained molecular weight 
standards are indicated on the right. Bands corresponding to the 72-kDa and 
92-kDa enzymes were detected in blister fluid. 
further indicated that detectable activities of the 92-kDa and 72-
kDa enzymes are found in various blistering diseases and even in 
normal skin. The ratio of the 92-kDa to 72-kDa enzymes varied in 
various blistering diseases perhaps due to the various levels of blister 
formation, various degree of inflammation, and the variable degrees 
of injury to the epidermis and dermis induced by blister formation. 
Even though high levels of the 92-kDa enzyme were found in some 
patients with bullous pemphigoid, it is too early to speculate the role 
of this enzyme in blister formation in this disease. Because it is 
known that type IV collagenase is capable of degrading different 
proteins, such as type IV and VII collagens (see Introduction), which 
have a central role in dermoepidermal junction, it may participate 
in, or enhance, blister formation in several blistering diseases. 
The origin of 92-kDa type IV collagenase in the various blister-
ing diseases studied here is currently unknown. It is possible that 
some of 92-kDa enzyme found in blister fluids is derived from 
inflammatory cells that are abundantly present in several blistering 
diseases [19] . For example, polymorphonuclear leukocytes and eo-
sinophils may be present in erythema multiforme and bullous pem-
phigoid [19] as also found in the present study. Erysipelas is also 
characterized by a heavy leukocyte infiltration [20] . Previously, it 
Figure 5. The expression of 92-kDa type IV collagenase mRNA in the 
regenerated epidermal cells (E) (arrows) in a 48-h blister. The signal in the 
endothelial cells is marked with arrowheads. Scale bar, 50/-1. 
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Figure 6. The expression of the 72-kDa type collagenase mRNA is prescnt 
in the dermal fibroblasts (arrows) bcneath a 48-h bliste r (B). N ote that at this 
location blister floor has not yet been covered by new epidermis. The cells in 
the detac hed epidermis (E) are negative. Scale bar, 50 It. 
has been shown that various inflammatory cells, such as polymor-
phonuclear leukocytes and macrophages, contain 92-kDa type IV 
co llagenase activity [2]. Thus, it is possible that, in diseased skil), 
some of the 92-kDa enzyme could be derived from injured epider-
mis and inflammatory cells. 
Type IV collagenase may have a particularly important role in the 
re-epithelialization of wounds. H ere, we have devised a suction-
blister model that can be used ill IlillO to study the regeneration of the 
skin in humans. W e were able to detect a significant induction of 
the 92-kDa enzyme during re-epithelialization, both by zymo-
graphy and by i" sit II hybridization. This is in agreement with 
previous studies in which type IV collagenase has been shown to 
have an important role in tumor invasion and wound healing (see 
Introductioll; [21 D. It is possible that, during the migration of epithe-
lial cells, cells abundantly produce type IV collagenase, which may 
fac ilitate cell movement. Transforming growth factor beta 1, which 
enhances wound healing, has been shown to induce the 92-kDa 
activity in keratinocytes, further supporting the role of 92-kDa 
co llagenase in re-epithelialization [8] . Interestingly, the fibroblasts 
also contained high levels of mRNA of the 72-kDa enzyme during 
regeneration, suggesting that re-epithelialization process also .in-
volves dermal elements. This was supported by the fact that, dunng 
regeneration, mRNA of the 92-kDa enzyme in proliferating e~d~­
thelial cells of blood vessels was abundantly present. TI1lS may mdl-
care that angiogenesis during re-epithelialization involves the acti-
vation of the 92-kDa enzyme faci litating blood-vessel formation . 
Indeed, previous studies have shown that, in the experimentalneo-
vascularization model, migrating endothelial cells produce type IV 
collagenolytic activity [22] . . 
The suction blister model was used to study the effects of topical 
gl ucocorticoids and all-trans-retinoic acid on type I~ collagenase. 
Glucocorticoids constitute the main treatment modality for vanous 
inflammatory skin diseases and bullous diseases. Ninety-two-
kilodalton type IV collagenase activity was down-regulated follow-
ing a relatively short (2 d) treatment with topical glucocorticoid. 
The lack of suppression of72-kDa form With topical steroids could 
be due to diminished bioavailability of the topical steroid to the 
dermal fibrobl as ts. Previous studies have shown that glucocorti-
coids decrease interstitia l collagenase activity [23] . In lIitro studies 
have also revea led that type IV collagenolytic activity was reduced 
in HT -1080 cells and human skin fibroblasts in response to gluco-
corticoids ill lIitro [24,25] . This is the first demonstration that gluco-
corticoids also inhibit type IV collagenase in human skin in lIillo. 
This finding may have a great clinical significance for the trea~ment 
of b listering diseases. It should also be noted that glucocorticOids 
increase the sy nthesis of [26] plasminogen ac tivator inhibitor-1, 
which has an important role in the plasminogen-plasmin cascade 
[27]. In addition it is known that plasmin can increase type IV 
collagenolytic activity through ac tivation of the pro-enzyme [27] . 
Thus, it is possible that glucocorticoids have at least a dual ll1hlbl-
tory effect on type IV collagenase in blisterin~ diseases, firstly by 
directly inhibiting type IV collagenase syntheSIS and, second ly, by 
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Figure 7. The expression of72-kDa type IV collage nase mRNA in normal 
epidermis (E) shows occasional positively labeled cell s in the basal layer 
(arrows) (0, dermis) . Scale bar, 5011. 
inhibiting its activation. Topical all-trans - retinoic acid did not ex-
hibit such marked actions on type IV collagenase as glucocorticoids. 
It is possible that longer treatment would give different results. 
This stlldy was partially slipported by gra II ts from the Medical Research COlilleil oj 
ti,e Academy oJFilllatld, the Yrjii JaIIlISSOII FOlilldatioll, alld the Pali/o FO,/lidatioli . 
We ackllowledge Ms. A lilia Alltio Jor her expert secretariallVork, Ms. Sirpa Kallgas 
Jor her excellellt ,ecllllical assistallce, alld Dr. Malti HOY/llyn Jor assayillg type IV 
collagwolytic activity. We aclmowledge Dr. Birkedal-HaliseliJor providillg 72-kDa 
type IV collagwase alltibody Gild Dr. Mllrphy Jor providillg 92-kDa type IV colla-
get/ase alllibody. 
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ANNOUNCEMENT 
The workshop Mouse Mutations as Animal Models and Biomedical Tools: Skin and Hair 
Mutations will be held at The Jackson Laboratory, Bar Harbor, Maine, September 29 to 
October 2, 1993. 
This workshop will present spontaneous mouse mutations with skin and hair abnormalities 
that are useful for a variety of biomedical studies. Live mice and study sets of histologic materials 
will be avai lable for examination. Seminars will be held on current research in dermatology 
with emphasis on mouse-human homologies. 
The American Academy of Dermatology certifies that this educational activity has been 
recognized for 17 hours of AAD Category I credit and may be used toward the AAD's CME 
Award . 
For further information, contact Suzanne Serreze, The Jackson Laboratory , 600 Main Street, 
Bar Harbor, ME 04609-1500. Tel. 207/288-3371; Fax 207/288-8254. 
